Tim O’Connor
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Genetic Associations and Epidemiology
- Genomics and Rare Diseases
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 11
- Genetic Associations and Epidemiology 10
- Genomics and Rare Diseases 1
-
- Acute Myeloid Leukemia Research 2
- Journals
- Nature Communications (7 papers)Nature Genetics (5 papers)Nature (3 papers)Nature Methods (1 paper)Nature Computational Science (1 paper)
- Partner nations
- United StatesFinland
In The Last Decade
Tim O’Connor
21 papers receiving 1.9k citations
Tim O’Connor's Hit Papers
Peers
Comparison fields: 5 of 65
- Hematology 398
- Genetics 522
- Aging 6
- Cancer Research 48
- Genetics 30
Countries citing papers authored by Tim O’Connor
This map shows the geographic impact of Tim O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim O’Connor more than expected).
Fields of papers citing papers by Tim O’Connor
This network shows the impact of papers produced by Tim O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim O’Connor. The network helps show where Tim O’Connor may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inherited causes of clonal haematopoiesis in 97,691 whole genomes Hit paper breakdown → | 2020 | 555 |
| 2 | Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data Hit paper breakdown → | 2022 | 229 |
| 3 | 2020 | 166 | |
| 4 | Clonal haematopoiesis and risk of chronic liver disease Hit paper breakdown → | 2023 | 151 |
| 5 | 2018 | 135 | |
| 6 | 2021 | 132 | |
| 7 | 2018 | 89 | |
| 8 | 2023 | 75 | |
| 9 | 2020 | 72 | |
| 10 | 2022 | 67 | |
| 11 | 2022 | 47 | |
| 12 | 2021 | 35 | |
| 13 | 2022 | 33 | |
| 14 | 2022 | 31 | |
| 15 | 2021 | 22 | |
| 16 | 2021 | 22 | |
| 17 | 2021 | 16 | |
| 18 | 2025 | 15 | |
| 19 | 2023 | 13 | |
| 20 | 2025 | 7 |
About Tim O’Connor
Tim O’Connor is a scholar working on Genetics, Hematology, Physiology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (10 papers), Acute Myeloid Leukemia Research (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Liver Disease Diagnosis and Treatment (1 paper), Obstructive Sleep Apnea Research (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Asthma and respiratory diseases (1 paper) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Hematology (398 citations), Genetics (522 citations), Aging (6 citations), Cancer Research (48 citations) and Genetics (30 citations). Tim O’Connor has collaborated with scholars based in United States and Finland. Their work appears in journals such as Nature Communications, Nature Genetics, Nature, Nature Methods and Nature Computational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.